| |
|
|
|
Amneal Pharmaceuticals Inc.  
|
|
4.65 0.29 (0.07%) |
07-10 16:00 |
|
Open: |
4.31 |
Pre close: |
4.36 |
Target:
|
5.91
|
|
High: |
4.72 |
Low: |
4.3 |
Resistance:
|
5.06
5.56
|
|
Volume: |
1,536,202 |
Market Cap: |
1450M |
Support:
|
4.25
3.54
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.55
 |
MACD |
MACD(12,26):
|
-0.02 |
|
MA(20): |
4.70 |
Signal(12,26,9): |
0.04  |
|
MA(100): |
3.99 |
Stochastic Oscillator |
%K(14,3):
|
22.80 |
|
MA(250): |
3.77 |
%D(3): |
21.56 |
|
Average Volume(K) |
3-Month: |
172121
|
52-Week |
High:
|
5.79 |
|
10-Days: |
114865 |
Low: |
2.27 |
|
RSI |
RSI(14):
|
50.43 |
Change(%): |
32.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.455 |
Return on Equity (ttm) |
-58.8 |
Shares Out. (M) |
147.31 |
|
EPS Est. Current Year |
0.000 |
Return on Assets (ttm) |
1.4 |
Shares Float (M) |
94.10 |
|
EPS Est. Next Year |
0.000 |
PEG Ratio |
0.00 |
% Held by Insiders |
10.36 |
|
EPS Est. Next Quarter |
0.000 |
Qtrly Rev. Growth |
11.7 |
% Held by Institutions |
69.44 |
|
Forward EPS |
-2.740 |
Gross Profit (p.s.) |
3.373 |
Shares Short (K) |
5830 |
|
Book Value (p.s.) |
2.160 |
EBITDA (p.s.) |
2.112 |
P/E |
-3.20 |
|
Sales Per Share |
11.405 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.15 |
|
Profit Margin |
-11.85 |
Operating Cash Flow
(M) |
159.14 |
P/S |
0.41 |
|
Operating Margin |
5.64 |
Levered Free Cash Flow
(M) |
5.88 |
P/CF |
4.30 |
|
|
|
|
|
|
